Syros Pharmaceuticals Stock Overlap Studies Triple Exponential Moving Average T3
| SYRS Stock | USD 0.29 0.03 11.54% |
| Symbol |
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Syros Pharmaceuticals price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Syros Pharmaceuticals Technical Analysis Modules
Most technical analysis of Syros Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Syros from various momentum indicators to cycle indicators. When you analyze Syros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Syros Pharmaceuticals Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Syros Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Syros Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Syros Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Syros Pharmaceuticals's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Syros Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Syros Pharmaceuticals, we also check how macroeconomic factors affect Syros Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 46.29 | 41.55 | 47.79 | 45.4 | PTB Ratio | 2.39 | 0.36 | 13.24 | 13.91 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for Syros Stock Analysis
When running Syros Pharmaceuticals' price analysis, check to measure Syros Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Syros Pharmaceuticals is operating at the current time. Most of Syros Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Syros Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Syros Pharmaceuticals' price. Additionally, you may evaluate how the addition of Syros Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.